St. Clair Man Is First in Mich to Receive Novel Cancer Treatment GammaTile
A cancer patient at Henry Ford with a recurring brain tumor is the first person in Michigan to receive an implanted device as treatment.
41-year-old Thomas Groves II from St. Clair received surgically targeted radiation therapy called GammaTile Therapy. Groves said he hopes this can lead to a medical breakthrough ultimately helping many.
